Cliantha Research has an impeccable track record of over 72 years and is a leading provider of Dermatology Clinical Research Services.
With Cliantha’s immense dermatological research experience, we have the ability to cater to the growing market needs, dynamic market trends and current regulatory requirements in dermatology product testing. With the strategic acquisition of Hill Top Research in North America, the enhanced service portfolio offered to our clients helps provide a smooth and easy study solution in the Dermatology segment.
For your Dermatology Clinical Research needs, we are able to offer a wide range of specialized services from our sites in India and North America. These services include but are not limited to Dermal safety and efficacy testing, PK endpoint clinical trials, patch studies/HRIPT, adhesion studies (for topical and transdermal products), Vasoconstriction studies for Glucocorticosteroids as well as photo-toxicity studies. All trials can be conducted in our controlled in-house environment facilities, or through the out-patient in home trial alternative. We can assist you in determining the best design for your organizations trial. Each trial is customized to present our clients with end-to-end services including design, recruitment, project management, and reporting and manuscript publication.
Cliantha also specializes in manufacturing the ‘Occlusive’ Dermal Delivery System "Hill Top Chambers"
Cliantha Research has several decades of experience in conducting and analysing Dermatology clinical studies for Pharmaceuticals, Biotechnology, Nutraceuticals, Herbal, Cosmetics and Consumer Research companies. We have robust expertise in conducting Phase I IND to Phase IV dermatology safety and efficacy studies and following dermatology clinical trials.
At Cliantha Research, our multiple clinical pharmacology units allow for the conduct of phase I-II studies in healthy and targeted patient populations and Environmental Controlled Hot-/Cold Room to conduct studies in controlled temperature and humidity.